Product
Triamcinolone Hexacetonide
Aliases
TH
Name
Hexatrione
INN Name
triamcinolone hexacetonide
FDA Approved
Yes
6 clinical trials
1 organization
8 indications
1 document
Indication
OsteoarthritisIndication
KneeIndication
Osteoarthritis, KneeIndication
Carpal Tunnel SyndromeIndication
KeloidIndication
ScarIndication
InfiltrationIndication
Juvenile Idiopathic ArthritisClinical trial
A Randomized, Double-Blind, Placebo Controlled, Multi-Center Study of a Single Injection Cross-Linked Sodium Hyaluronate Combined With Triamcinolone Hexacetonide (Cingal®) to Provide Symptomatic Relief of Osteoarthritis of the KneeStatus: Completed, Estimated PCD: 2022-05-16
Clinical trial
Trial Extension Protocol to Add a 39 Week Follow Up to Cingal 16-02, a Randomized, Double-Blind, Active Comparator Controlled, Multi-Center Study of a Single Injection of Cingal to Provide Symptomatic Relief of Knee OsteoarthritisStatus: Completed, Estimated PCD: 2018-07-30
Clinical trial
The NOR-CACTUS Trial - A Norwegian Trial Comparing Treatment Strategies for Carpal Tunnel SyndromeStatus: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
Effect of the Combination of Photobiomodulation Therapy and the Intralesional Administration of Corticoid in the Preoperative and Postoperative Periods of Keloid Surgery: a Randomized, Controlled, Double-blind TrialStatus: , Estimated PCD: 2023-12-01
Clinical trial
A Randomized Single-blinded Clinical Trial of the Efficacy of Intra-articular Infiltration of Cingal (Sodium Hyaluronate/Triamcinolone) Versus Cortisone (Triamcinolone) in Patients With Osteoarthritis of the Shoulder.Status: Recruiting, Estimated PCD: 2026-09-01
Clinical trial
Strategies Towards Personalised Treatment in Juvenile Idiopathic Arthritis (JIA): The MyJIA Trial.Status: Active (not recruiting), Estimated PCD: 2024-12-16
Document
DailyMed Label: HexatrioneOrganization
Medexus Pharma, Inc.